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Mapping B-cell responses to 
Salmonella enterica serovars 
Typhimurium and Enteritidis in 
chickens for the discrimination of 
infected from vaccinated animals
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Serological surveillance and vaccination are important strategies for controlling infectious diseases 
of food production animals. However, the compatibility of these strategies is limited by a lack of 
assays capable of differentiating infected from vaccinated animals (DIVA tests) for established killed 
or attenuated vaccines. Here, we used next generation phage-display (NGPD) and a 2-proportion Z 
score analysis to identify peptides that were preferentially bound by IgY from chickens infected with 
Salmonella Typhimurium or S. Enteritidis compared to IgY from vaccinates, for both an attenuated 
and an inactivated commercial vaccine. Peptides that were highly enriched against IgY from at least 4 
out of 10 infected chickens were selected: 18 and 12 peptides for the killed and attenuated vaccines, 
respectively. The ten most discriminatory peptides for each vaccine were identified in an ELISA using a 
training set of IgY samples. These peptides were then used in multi-peptide assays that, when analysing 
a wider set of samples from infected and vaccinated animals, diagnosed infection with 100% sensitivity 
and specificity. The data describes a method for the development of DIVA assays for conventional 
attenuated and killed vaccines.
The serological surveillance of immune responses to animal pathogens is vital for the control of diseases of 
farmed animals. Serological techniques commonly used to quantify specific antibody responses include aggluti-
nation assays and ELISA tests and will often use antigens such as flagellin, lipopolysaccharides and outer mem-
brane preparations1. A significant drawback of this approach is that vaccine use is often limited due to their 
interference with serological surveillance that results from an inability to differentiate infected from vaccinated 
animals (DIVA). For example, Solano and co-workers found that a commercial flagellin-antigen assay could not 
differentiate any S. Enteritidis infected chickens from those vaccinated with a commercial bacterin vaccine2. They 
also investigated ELISAs based on lipopolysaccharide, O-polysaccharide or membrane sediment antigens but 
these also had poor specificity as DIVA assays (18, 77 and 1% specificities, respectively). Several strategies have 
now been developed to produce DIVA vaccines, the most common is the genetic manipulation of the vaccine 
strain to remove a serologically dominant component, whose recognition would then diagnose an infection. 
Drawbacks with such an approach are the need to engineer a new vaccine, associated regulatory implications for 
genetically modified vaccines, and also that the removal of a highly immunogenic component can reduce vaccine 
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efficacy3. Alternative approaches include the use of subunit vaccines4 or virus-like particle vaccines5. Effective 
DIVA vaccines and their accompanying assays allow mass vaccination of animal populations during a disease 
outbreak without any loss in the ability to diagnose infected animals. However, there are a wide variety of vaccines 
approved for use in domestic animals and the majority are “conventional” vaccines using attenuated or inactivated 
pathogen4 that have no accompanying DIVA assays.
Salmonella enterica serovars Typhimurium and Enteritidis are major zoonotic pathogens in pigs and poultry 
and are some of the most common food borne pathogens affecting humans6. In both pigs and poultry the use of 
vaccination and serological surveillance has remained largely incompatible due to a lack of suitable DIVA tests. 
Vaccination against Salmonella infection in poultry is widespread resulting in limited application of serological 
testing7. In contrast, Salmonella infection in pigs is largely controlled by serological surveillance and the develop-
ment and uptake of vaccination is limited3.
Both live attenuated and killed commercial vaccines are available for use in the poultry industry. Examples of 
attenuated vaccines are the metabolic drift vaccines S. Enteritidis strain Sm24/Rifl2/Ssq (AviPro SALMONELLA 
VAC E) and S. Typhimurium strain Nal2/Rif 9/Rtt (AviPro SALMONELLA VAC T)8. An example of a commer-
cial killed Salmonella vaccine is Nobilis SalenVac T which is effective against S. Typhimurium and S. Enteritidis 
infections9,10. A further killed vaccine, Layermune S. Enteritidis, contains various S. Enteritidis strains and pro-
tects against this serovar11. Similarly, Poulvac SE is an inactivated Salmonella vaccine strain that is composed of 
three S. Enteritidis phage types (4, 8, and 13a)12. Whilst effective killed and attenuated vaccines are available for 
Salmonella infections, accompanying DIVA tests are not.
Here, by mapping B-cell responses in infected and vaccinated chickens using next generation phage-display 
(NGPD), it was possible to develop DIVA tests against both inactivated and attenuated commercial Salmonella 
vaccines.
Results
Phage-peptides were panned against IgY from 10 infected chickens over two rounds and in the second round 
the phage-peptides were bound in parallel to pools of IgY from 10 chickens vaccinated with either a killed or 
attenuated vaccine. The peptide gene regions of eluted phage were sequenced and peptides that were enriched 
specifically against infected-IgY compared to that from vaccinates were identified using a 2-proportion Z test. 
A Z-score cut-off of 8.0 was used to define very high specific enrichment. Multiple peptides were very highly 
enriched in 4 or more of the 10 infected chickens (Tables 1 and 2). With both vaccine types, a training set of 
samples was used to define the most diagnostic synthetic peptides within an ELISA test. This training set was 
made up of IgY from 8 chickens infected with S. Typhimurium, 9 infected with S. Enteritidis and 10 vaccinated 
chickens for each vaccine. This training set included all samples used in the phage panning experiment. ELISA 
signals for each peptide were analysed by ROC curve and the 10 most discriminatory peptides for each vaccine 
(as measured by the AUC; Tables 1 and 2) were selected and used to analyse IgY from a wider range of infected 
and vaccinated chickens (Tables 1 and 2, Fig. 1). In total, peptides were analysed for binding against IgY samples 
from 16 chickens infected with S. Typhimurium, 19 infected with S. Enteritidis and 20 vaccinates for each vaccine 
type (these samples include the training set). The most diagnostic individual peptide for the killed vaccine had 
a sensitivity and specificity of 80% and 100%, respectively (Table 1, Fig. 1A) and the equivalent peptide for the 
attenuated vaccine had 94% sensitivity and 100% specificity (Table 2, Fig. 1B). However, by using the 10-peptide 
cohorts as multi-peptide assays where infection was defined as reactivity to one or more peptides, then the DIVA 
assays for both vaccines had 100% sensitivity and specificity (Fig. 1C,D) for diagnosing infections.
Discussion
Serological surveillance of farmed animals for infectious diseases is a vital component of disease control strate-
gies. The use of effective vaccines can be restricted by the lack of accompanying DIVA tests that allow continued 
serological surveillance for infection after widespread vaccination. Considerable research effort has gone into 
designing and producing so-called marker vaccines that have an accompanying DIVA test. There are various 
strategies to develop marker vaccines but all require significant investment in the development of new vaccines 
and their validation.
For Salmonella infections, several experimental vaccines are under development. For application in pigs, 
Leyman and co-workers describe a S. Typhimurium vaccine that is based on LPS mutations13 and Selke and 
co-workers describe an isogenic mutant of the licensed attenuated Salmonella strain (Salmoporc) that lacks the 
outer membrane porin D gene2. For application in poultry, a S. Enteritidis phoP/fliC deletion mutant vaccine is 
under development14. To date there is limited scope to develop DIVA assays for existing conventional (killed or 
attenuated) vaccines, which make up the vast majority of vaccines for production animals4. One option is to iden-
tify genetic differences between vaccine strains and circulating wild-type strains of a pathogen. However, such 
assays can be relatively complicated and can be compromised by genetic mutations in the wild type pathogen15,16.
We recently reported an effective NGPD method to map B-cell responses to infection17. The method is based 
on the parallel binding of phage-peptide libraries to polyclonal IgY/IgG from a target cohort (e.g. infected ani-
mals) and a control cohort (e.g. healthy animals). NGS analysis of bound phage-peptide genes allows the assess-
ment of thousands of peptides binding to target and control antibody samples across multiple animals. Here, we 
applied this methodology to identify peptides that were specifically bound by antibody from Salmonella-infected 
chickens compared to from one of two conventional commercial vaccines, a live attenuated vaccine and a killed 
vaccine. Eighteen and twelve peptides for the killed and attenuated vaccine, respectively, were identified as being 
specifically and highly enriched in at least 4 out of 10 infected chickens. The serological recognition of synthetic 
peptides in ELISAs demonstrated that all of these peptides were highly discriminatory. The most diagnostic indi-
vidual peptide that could differentiate infected animals from those vaccinated with the killed vaccine had 80% 
sensitivity and 100% specificity, similarly a single peptide could detect infected animals over those vaccinated 
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with an attenuated vaccine with 94% sensitivity and 100% specificity. The method identified multiple diagnostic 
peptides and when the 10 most highly discriminatory peptides for each vaccine type were used in a multi-peptide 
serological assay, these two assays both had 100% sensitivity and specificity for detecting infection.
Interestingly, two of the diagnostic peptides identified were the same for both vaccines indicating that these 
infection-specific epitopes are not recognized for either vaccine type. The absence of shared epitopes could result 
from bacteria in both vaccines not presenting certain virulence factors and processes due to attenuation, in vitro 
growth and/or destruction of conformational epitopes during vaccine denaturation. This may well result in 
similar methods of antigen presentation after administration that is distinct from the wild type pathogens. For 
instance, a lack of virulence factors/processes favours the presentation of extracellular antigens and subsequent 
presentation via MHC II complexes. It is reasonable to expect that such antigen processing will favour the absence 
(and presence) of some of the same epitopes for distinct vaccine types that are different from those for the wild 
type pathogens18.
The presented data show that mapping B-cell responses using NGPD can identify panels of peptides to dif-
ferentiate infected from vaccinated animals. These peptides can be used to design multi-peptide serological tests 
that allow the development of very highly specific and sensitive DIVA tests for conventional (attenuated or killed) 
vaccines. This method may extend the use of established conventional vaccines in disease control strategies as an 
alternative to the development of new marker vaccines.
Methods
Animal challenge studies. The animal procedures were conducted at the APHA under the jurisdiction of, 
and in accordance with, a UK Home Office project licence (Animals Scientific Procedures Act, 1986 that were 
amended in January 13 by Directive 2010/63/EU). All studies were approved by the local APHA Ethics Review 
Committee.
Hy-line layer chickens were used throughout. Several S. Enteritidis (19 birds in total) and S. Typhimurium 
(16 birds in total) challenge experiments were conducted and are described in detail elsewhere17. All chickens 
were challenged via oral gavage between 98 and 140 days old and blood samples taken 13 or 14 days later.
The commercial inactivated vaccine (Nobilis SalenVac T, MSD-Animal Health) was an inactivated vaccine 
made up of S. Enteritidis PT4, and S. Typhimurium DT104 and designed for protection against both serovars9,10. 
Peptide sequencea In silico assessmentb
ELISA assessment
AUC of 
ROCc sensitivityd specificityd
CSSPPRSAGTCG 7/10 1 80 100
AEGEFAHSGTADVK 7/10 1 63 100
CYRLQELALGCG 6/10 1 77 100
AEGEFTAARSNHQP 6/10 1 77 100
CTQRRSLVFSCG 5/10 1 54 100
AEGEFPHNTQPQES 5/10 0.994 71 100
AEGEFIALHSQPPL 5/10 0.966 54 100
AEGEFILHKGFVRW 5/10 0.994 74 100
AEGEFQYSSQQGRL 4/10 0.947 9 100
AEGEFQQVHFKKHE 4/10 1 57 100
AEGEFTTRHSVATW 4/10 0.994 66 100
CGPSKPPLQYCG 4/10 0.938 37 100
CVSPLQSQISCG 4/10 0.999 80 100
CLQSKRPCPHCG 4/10 0.984 17 100
CLPVRSQGHSCG 4/10 0.988 46 100
AEGEFRPGGRGGST 4/10 1 80 100
AEGEFQNLQIRHRT 4/10 0.916 57 95
AEGEFKIHNSPPTM 4/10 0.991 94 90
Control peptide — 0.509 — —
Table 1.  ELISA screening of candidate peptides identified by NGPD as being enriched against IgY from 
Salmonella infected chickens compared to from animals vaccinated with a killed vaccine. aResidues coded 
for by a stop codon were replaced by a Q in the synthesised peptide. Flanking cysteine residues for constrained 
peptides are underlined. bNumber of IgY samples that the peptide was very highly enriched against/total number 
of IgY samples: very high enrichment was defined using a Z score cut-off of ≥ 8.0. cROC curves were produced for 
the recognition of peptides with IgY from a training set of samples: infected (n = 8 for S. Typhimurium and n = 9 
for S. Enteritidis) and vaccinated (n = 10) chickens, AUC values are listed, for all peptides the associated p values 
were < 0.001. The control peptide associated p value was 0.940. dSensitivity and specificity values were calculated 
from data for IgY binding to each peptide from infected (n = 16 for S. Typhimurium and 19 for S. Enteritidis) and 
vaccinated (n = 20) chickens using cut-off values for each peptide calculated as the mean ELISA signal for the 
vaccinate samples in the training set (10 vaccinates used in the panning steps) plus 5SD. Sensitivity was calculated 
as the % of infected chickens that gave signals above the cut-off value and the specificity is the % of vaccinates that 
gave signals below the cut-off value.
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Twenty birds received two doses (0.5 ml in breast muscle) at 85 and 113 days old. Blood samples were taken at 124 
days old. The commercial attenuated vaccine was a mixture of 1– 6 × 108 CFU each of attenuated S. Enteritidis 
strain Sm24/Rifl2/Ssq and attenuated S. Typhimurium strain Nal2/Rif 9/Rtt (AviPro SALMONELLA VAC E and 
AviPro SALMONELLA VAC T, respectively, Lohmann Animal Health). Twenty birds received three doses (0.1 ml 
oral gavage) of these live attenuated metabolic drift vaccine strains8 via oral gavage at 2, 44 and 106 days old, 
blood samples were taken at 127 days old.
Purification of IgY. Chicken IgY was purified by Thiophilic gel chromatography (Thermo-Scientific, UK)19. 
Eluted fractions were assayed by ELISA using Anti-Chicken IgY-Alkaline Phosphatase (AP) antibody produced 
in rabbit (Sigma-Aldrich, UK) and fractions containing IgY were pooled. Protein content was estimated using a 
Bradford reagent (Sigma-Aldrich, UK) before sample storage at 4 °C.
Panning of phage-peptides against purified antibody. Two peptide phage-display libraries20,21 were 
used for biopanning experiments. Both libraries display random 9 amino acid peptides on coat protein VIII and 
have diversities of ~107, one library displays linear peptides and the other displays peptides constrained between 
two cysteine residues. Panning was carried out as previously described16. Briefly, libraries were pooled and panned 
against IgY (20 μ g/ml immobilised on 10 maxisorb plastic microtitre wells per sample) from each of 10 chickens 
infected with S. Typhimurium (n = 5) or S. Enteritidis (n = 5). Following phage binding, wells were washed 20x 
with PBS (10 mM phosphate buffer pH 7.2–7.4 with 150 mM NaCl) plus 0.1% (v/v) Tween (PBST) and then 20x 
with PBS. Bound phage was competitively eluted using a Salmonella lysate (a 1:1 mixture by protein content 
of lysate from S. Enteritidis and S. Typhimurium produced as previously described22; 1 mg /ml, 100 μ l /well). 
Eluted phage from each antibody sample were propagated in Escherichia coli TG1 supE thi-1 ∆ (lac-proAB) 
∆ (mcrB-hsdSM)5(rK–mK) (F ́ traD36 proAB lacIqZ∆ M15) and then pooled to produce a sub-library of phage 
that was then panned against IgY from each of the same 10 infected chickens and in parallel was panned against 
IgY pooled from 10 chickens vaccinated with either the killed or attenuated vaccine. Panning steps were the 
same as in round 1 except IgY from each animal was immobilised in 4 wells and washing was 20x in PBST-BSA 
(0.1% Tween 20, 500 μ g/ml BSA, and wash solution incubated in wells for 2 min for each wash) and 20x in PBS. 
Competitively eluted phage for each IgY sample from round 2 was then propagated in E. coli TG1 and stored at 
− 80 °C in 30% (w/v) glycerol.
DNA extraction and sample preparation for Ion Torrent sequencing. Bacteria was grown overnight 
in 2YT with ampicillin and the phagemid DNA extracted, amplified by PCR and sequenced using an Ion Torrent 
PGM service (University of Pennsylvania, US) on a 318 chip exactly as previously described17. During this pro-
cedure, phagemid originating from selection against each IgY sample were tagged with a unique DNA barcode.
Peptide sequencea In silico assessmentb
ELISA assessment
AUC of 
ROCc sensitivityd specificityd
AEGEFQNLQIRHRT 8/10 1 94 100
AEGEFTQTKRNMSW 5/10 0.997 77 100
CPSTLRQPCSCG 5/10 1 80 100
AEGEFLPKHKQNGG 4/10 1 54 100
AEGEFFAASCTRQL 4/10 0.938 91 100
CSIFQYTALQCG 4/10 1 40 100
AEGEFTAARSNHQP 4/10 1 89 100
AEGEFAQNSHLYPQ 4/10 0.966 69 100
AEGEFLSTMARSRS 4/10 0.981 74 100
CQTAVPSFMVCG 4/10 0.903 66 100
CIALQQVCGLCG 4/10 0.894 34 100
CPTRVIQPKPCG 4/10 0.984 71 100
Control peptide — 0.588 — —
Table 2. ELISA screening of candidate peptides identified by NGPD as being enriched against IgY from 
Salmonella infected chickens compared to from animals vaccinated with an attenuated vaccine. aResidues 
coded for by a stop codon were replaced by a Q in the synthesised peptide. Flanking cysteine residues for 
constrained peptides are underlined. bNumber of IgY samples that the peptide was very highly enriched 
against/total number of IgY samples: very high enrichment was defined using a Z score cut-off of ≥ 8.0. cROC 
curves were produced for the recognition of peptides with IgY from a training set of samples: infected (n = 8 
for S. Typhimurium and n = 9 for S. Enteritidis) and vaccinated (n = 10) chickens, AUC values are listed, for 
all peptides the associated p values were < 0.001. The control peptide associated p value was 0.451. dSensitivity 
and specificity values were calculated from data for IgY binding to each peptide from infected (n = 16 for  
S. Typhimurium and 19 for S. Enteritidis) and vaccinated (n = 20) chickens using cut-off values for each 
peptide calculated as the mean ELISA signal for the vaccinate samples in the training set (10 vaccinates used in 
the panning steps) plus 5SD. Sensitivity was calculated as the % of infected chickens that gave signals above the 
cut-off value and the specificity is the % of vaccinates that gave signals below the cut-off value.
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Next generation sequencing (NGS) data analysis. Data was analysed as previously described17. Perl 
scripts were used to process NGS data files. Scripts used for data processing are provided at http://figshare.com/
articles/Mapping_B_cell_responses_to_bacterial_infection_using_next_generation_phage_display/1566818. 
Briefly, FASTQ files were converted to FASTA files and Ion Torrent barcodes used in each experiment identified 
using the “FASTQ/A Barcode splitter” (part of the FASTX-toolkit from http://hannonlab.cshl.edu/fastx_toolkit/
index.html). DNA sequences in each barcode-binned FASTA file were translated in all 3 frames and concate-
nated to a single file (translate.pl). FASTA files were processed to identify matching flanking sequence motifs 
(AEGEF and DPAKAA) to capture insert (peptide) sequence. Parameter choices for analysis of data were as 
follows, a maximum 0 mismatches allowed per barcode, minimum of 1 amino acid between flanking motifs for 
subsequent analysis, all stop codons replaced with amino acid Q. Each peptide sequence obtained against each of 
the 10 “infected IgY” samples was compared to the set of peptide sequences obtained against the “killed vaccine 
IgY pool” and separately against the “attenuated vaccine IgY pool” using a two proportion Z test as previously 
described17. A peptide was defined as being very highly enriched against an “infected IgY” sample if it gave a Z 
score of ≥ 8.0. For each vaccine type, peptides were then further ranked on how many different IgY samples from 
infected chickens they were highly enriched against.
Peptide Synthesis. Linear peptides identified as being very highly enriched against IgY from multiple 
infected animals were synthesised with an amidated C-terminus and with the protein VIII N-terminal residues 
AEGEF, constrained peptides contained a C-terminal G residue as the only vector-derived residue (Tables 1 and 2). 
An unrelated control peptide (HVMDADQESVSQSDI) was used as a control throughout these screening exper-
iments. All peptides were synthesised by GeneCust Europe (Laboratoire de Biotechnologie du Luxembourg S.A) 
at the crude purity level (> 49% pure) and 5 mg scale. The synthetic peptides were then dissolved and diluted to a 
stock concentration of 2 mg/ml.
Figure 1. IgY recognition of Salmonella epitopes/mimotopes. Purified IgY from infected (S. Typhimurium 
or S. Enteritidis, n = 16 and n = 19, respectively, numbers 1–16 and 17–35 respectively in (C,D) and vaccinated 
(n = 20 for both the killed (A,C) and attenuated (B,D) vaccines, numbers 1–20 in (C,D) chickens was analysed 
for binding to synthetic peptides. Bound IgY was detected with an anti-IgY-AP conjugate. All samples were 
analysed in duplicate. Example discriminatory individual peptides for the killed (A) or attenuated (B) vaccine 
are shown. The cut-off values (dotted lines in (A,B) were calculated as the mean + 5SD of the signals for the 
10 vaccinates used in the panning steps (training cohort, this is also applied for analysis in (C,D). The 10 most 
discriminatory peptides are shown as a multi-peptide ELISA for the killed (C) and attenuated (D) vaccine 
where binding of an IgY sample above the cut-off value for a peptide is shown as a grey box.
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ELISAs. Peptides (100 μ l, 100 μ g/ml) were coated in duplicate wells on maxisorb plastic in coating buffer 
(100 mM sodium carbonate-bicarbonate buffer, pH 9.6) at 4 °C overnight. Peptides coated wells were washed 1x 
with PBST and 1x with PBS and blocked with 3% (w/v) skimmed milk powder in PBS for 1 h and then washed 
as before. Antigen was probed with purified IgY (100 μ l/well, 20 μ g/ml) and following washing bound IgY was 
detected using an anti-chicken IgY-Alkaline Phosphatase conjugate (Sigma-Aldrich, UK; 1:20,000 in PBS con-
taining 3% (w/v) marvel, 100 μ l /well). Following washing, bound secondary antibody was detected with 100 μ l of 
p-Nitrophenyl Phosphate substrate (Sigma-Aldrich, UK). After 2 hours incubation with the substrate, absorbance 
was measured at 405 nm. All wash steps after the addition of IgY were 6x with PBST and 6x with PBS.
Analysis of ELISA data. All samples were analysed in duplicate and a mean calculated. For each IgY sample, 
there was a background control that had no immobilised peptide. The reading for this background was subtracted 
from all readings for that IgY sample before processing of the data. Receiver Operator Characteristic (ROC) 
analysis was carried out using Graph Pad Prism 6 for each peptide (including the control peptide) bound by the 
training set of IgY samples, area under the curve (AUC) and p values were generated using a 95% CI. A peptide 
was considered to be discriminatory if the p value was 0.05 or below. When using discriminatory peptides in 
serological assays, a cut-off value for each peptide was generated from the mean absorbance of the binding of 10 
vaccinate IgY samples (used in the panning experiment) plus 5 standard deviations.
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